# A Blood Change Can Leave You Feeling No Better > Research Peptide Fundamentals: What Helped Patients — Four peptides have very different evidence behind them. See what happened to people, what went wrong, and what remains unproved for you. **Four peptides / a blood test can’t settle your health** Peptides consist of joined amino acids; proteins are made from those small parts too. We’ll look at four peptides, starting with what happened to people and where proof stops. ### [GHK-Cu](/ghk-cu) GHK-Cu carries copper. Small tests found changes in skin or hair. That’s far less than proof of healing beyond your skin. ### [CJC-1295](/cjc-1295) The peptide raised growth hormone, a message involved in growth and repair. Small tests measured the change in blood. Lasting health gains weren’t shown. ### [Semaglutide](/semaglutide) Semaglutide acts like the gut’s GLP-1 hormone, a message that affects hunger and blood sugar. Patient trials found weight, heart, or kidney benefits, and possible harm. ### [Thymosin Alpha-1](/thymosin-alpha-1) The peptide changes immune cells, which fight infections within your body. The biggest test during dangerous infection didn’t clearly show fewer deaths. ## Semaglutide Has More Evidence of Health Benefits Look first at the effect on patients' health. Semaglutide has the strongest patient evidence of these four peptides. Patients lost weight; other trials found less serious illness involving kidneys or hearts. Those gains don't tell you whether this medicine fits your needs. Small GHK-Cu tests examined skin creams or mixtures applied to the scalp. Small studies of CJC-1295 found higher growth hormone. They didn’t show lasting gains in health. Early thymosin alpha-1 studies suggested fewer deaths during dangerous infection. The bigger test didn't clearly confirm fewer deaths. A blood number isn't the same as a health benefit. Suppose you're promised sounder sleep or more strength. Ask if researchers checked whether people slept better or gained strength. Finding a peptide in a lab sample can't answer that question. Nor can a rise in a blood hormone alone. You need researchers to measure the improvement named in that promise. When a claim concerns pain, sleep, or strength, a study needs to measure that same change in people over time before the claim can help you weigh a treatment. ## Testing Ingredients Doesn’t Tell You Whether Treatment Helps A trial asks what treatment did for the people studied. Semaglutide trials checked weight changes, kidney illness, and heart trouble [12][13][14]. A large thymosin alpha-1 trial counted deaths during dangerous infection [18]. More people didn't clearly survive with the peptide. Some received placebo, meaning the treatment contained no active drug. Both groups received ordinary medical care. Comparing the groups helped researchers judge what the peptide added. You need a health result when someone promises a health benefit. A sports drug-testing lab asked a different question [7]. The lab found CJC-1295 in material whose contents weren't known. No patients were treated in that test. Identifying the peptide didn't mean every harmful ingredient had been ruled out. Another experiment examined pieces of human skin after removal [5]. Copper entered that skin and stayed in deeper layers. Nobody received treatment to see whether healing improved. For you, the answer depends on what was tested, because identifying an ingredient, tracing copper through skin, and measuring health after treatment each address a different question about a peptide. A successful trial can't certify the contents of an unrelated research product. Your first question is what the test was meant to find. ## Copper and Added Parts Can Change a Peptide’s Effects A familiar name can cover more than one form. GHK-Cu joins copper to a peptide made of three parts [4]. GHK alone has no attached copper, making the forms different. Some peptides occur naturally in your body. Others have been changed in a lab to last longer. Neither natural origin nor lab manufacture proves safety for you. Ask whether the tested form matches the one being discussed. After CJC-1295, the gland under the brain releases more growth hormone. A gland is an organ that makes substances such as hormones. A hormone carries messages that direct work in different organs. One version has an added part called DAC. DAC binds to the protein albumin, which transports substances through blood. That attachment slows the peptide's departure from blood. The version without DAC lacks this attachment [6][9]. Their effects can't simply be treated as equal. Semaglutide acts like GLP-1, a gut hormone affecting appetite and sugar levels in blood. Some prescription forms have approved medical uses. Thymosin alpha-1 affects your immune system, which is how your body defends against illness. Some countries allow the peptide as medicine. US medicine sales aren't approved [19]. A research label doesn't change that limit. Your choice depends partly on which form was actually studied. ## A Lab Can Miss Harmful Substances It Didn’t Look For A passed test needs an explanation. First, did the lab identify the right peptide form? Copper makes GHK-Cu different from GHK alone. CJC-1295 versions can last for different periods. Second, which harmful substances did the lab search for? Unwanted ingredients won't necessarily appear in a test aimed at something else. Ask what passing tells you about the contents and which possible problems were left unchecked, because a test that looked for one substance may never have searched for another. Third, what result did the lab accept as good enough? Fourth, could a harmful amount escape the test's detection? An amount too small to measure can still be present. Fifth, how well has the test been checked for mistakes? Repeating the same mistake won't make an answer right. You deserve those limits in words that make sense. The studies discussed here didn't test every research product with these names. Researchers mostly examined people, cells, or material in a lab. A passed ingredient test still can't show that patients benefited. The [patient results](/compare) explain which health changes were actually measured. A lab can explain its ingredient checks. The doctor can help you assess the proof of a claimed health gain. Neither question disappears because someone says a product passed. ## Your Medicines and Illnesses Matter Alongside a Trial Result A group result can't choose your care. [Semaglutide](/semaglutide) has the clearest evidence of patient benefits here. In trials, a chance draw decided the treatment. Neither doctors nor patients could choose the group they wanted. Researchers then compared the health results. The answer concerns the medicine tested, with those patients. Other products bearing the same name weren't all tested. Tell the doctor about your illnesses and medicines, including anything you’re taking now. [GHK-Cu](/ghk-cu) has small skin tests with questions about copper and skin entry. [CJC-1295](/cjc-1295) changed blood hormone readings while lasting health gains stayed unproved. Results for DAC don't cover every version. The largest dangerous-infection trial of [Thymosin Alpha-1](/thymosin-alpha-1) didn't clearly show more survivors. Tell your doctor about past treatment problems too. Your present illnesses, medicines, and earlier reactions can change how the evidence applies to you, even when a trial found a benefit for its patients. --- An independent reading of peptide evidence, where methods and uncertainty stay attached to every claim—not a shop, clinic, or prescription.